| Literature DB >> 31074177 |
Yongbin Wu1, Jian Wen2, Weiwei Xiao3, Bao Zhang3.
Abstract
Pregenomic RNA (pgRNA) is an emerging serological marker for chronic hepatitis B virus (HBV) infection. While pgRNA is principally the template for viral proteins and viral DNAs, additional novel functions for the serum pgRNA have recently been described. These results extend for pgRNA a regulatory function in the viral life cycle and potentially a role in pathogenesis. Here, we review the diverse roles of pgRNA in HBV replication and pathogenesis, emphasizing how the unique structure of this RNA is key to its various functions. We focus in particular on the role of HBV pgRNA in guiding antiviral therapy including nucleot(s)ide analog interruption and role as a marker of cure with new curative therapies. We also briefly allude to the emerging niche for new direct-acting or indirect-acting antivirals targeting pgRNA.Entities:
Keywords: antiviral therapy; chronic hepatitis B; hepatitis B virus; marker; pregenomic RNA
Mesh:
Substances:
Year: 2019 PMID: 31074177 DOI: 10.1002/rmv.2051
Source DB: PubMed Journal: Rev Med Virol ISSN: 1052-9276 Impact factor: 6.989